CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,213 · Q3 • database DOAJ indexed
Orphan Drugs: Research and Reviews
New Zealand · Dove Medical Press Ltd.
workspace_premium Q3 — Drug Discovery visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Orphan Drugs: Research and Reviews

Orphan Drugs: Research and Reviews is a journal indexed in SJR in Drug Discovery and Pharmaceutical Science with an H index of 3. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1602 €. The scope of the journal is focused on orphan, drugs, disease, treatment. It has an SJR impact factor of 0,213 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,213.

Publisher: Dove Medical Press Ltd.
Category: Drug Discovery
Indexation: verifiedDOAJ
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,213 Q3
H-index 3
Acceptance rate pie_chart
74%
Source Acceptance_Rate
Time to publication hourglass_top
16 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
1.602 € Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

DOAJ

SJR Impact

0,213

H-index

3

Docs (year)

0

Docs 3y

4

Total refs

0

Cites 3y

5

Citable 3y

4

Cites/Doc 2y

0

Ref/Doc

0.0

Immediate OA

1602 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Orphan Drugs: Research and Reviews?

Orphan Drugs: Research and Reviews has an SJR of 0,213 (best quartile Q3) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is 1602 EUR.

What is the acceptance rate?

The acceptance rate recorded for Orphan Drugs: Research and Reviews is 74%.